Use of vitamin D in chronic kidney disease patients

Slides:

Advertisements

Similar presentations

Volume 79, Pages S3-S8 (April 2011)

Advertisements

Volume 67, Pages S1-S7 (June 2005)

A powerful new agonist: flooding the system with growth hormone

Volume 73, Issue 1, Pages 3-5 (January 2008)

Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward Adeera Levin, Paul E. Stevens Kidney International

Fibroblast Growth Factor 23 and CKD Prognosis

Anemia management in chronic kidney disease

Mitchell H. Rosner, W. Kline Bolton Kidney International

Volume 79, Issue 9, Pages (May 2011)

Volume 83, Issue 3, Pages (March 2013)

FGF23 or PTH: which comes first in CKD ?

Figure 4 Model of changes in the serum levels

Vitamin D deficiency and heart disease

Tilman B. Drüeke, Ziad A. Massy Kidney International

FGF23–parathyroid interaction: implications in chronic kidney disease

Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets David M. Spiegel, Kate Brady Kidney.

Prehypertension and chronic kidney disease: the ox or the plow?

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007 Joanna M. Smith, Susan A. Mott,

Reassessment of the care of the patient with chronic kidney disease

Volume 79, Pages S24-S27 (April 2011)

John P. Middleton, Patrick H. Pun Kidney International

Volume 79, Pages S3-S8 (April 2011)

M. Fukagawa, S. Nakanishi, J.J. Kazama Kidney International

Chapter 3: Management of progression and complications of CKD

Yasuhiro Hamada, Masafumi Fukagawa Kidney International

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Ten years of progress in our understanding of uremic vascular calcification and disease: a decade summarized in 20 steps Vincent M. Brandenburg, Markus.

Volume 70, Issue 11, Pages (December 2006)

Volume 79, Pages S20-S23 (April 2011)

Florian Lang, Michael Föller Kidney International

Volume 79, Issue 1, Pages (January 2011)

Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.

The calcium–phosphorus in guidelines for CKD-MBD

Vitamin D receptor: A highly versatile nuclear receptor

Volume 73, Issue 12, Pages (June 2008)

Volume 76, Issue 6, Pages (September 2009)

A physician's perseverance uncovers problems in a key nephrology study

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Volume 87, Issue 3, Pages (March 2015)

Methods for guideline development

Nephrology Crossword: Glomerulonephritis

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Volume 75, Issue 9, Pages (May 2009)

Fibroblast growth factor 23: the making of a hormone

Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell Kara K. Wools-Kaloustian, Samir K. Gupta Kidney.

Vitamin D in chronic kidney disease: is the jury in?

Cardio-Kidney-Damage: a unifying concept

Volume 81, Issue 1, Pages 7-9 (January 2012)

Latest findings in phosphate homeostasis

Pablo A. Ureña Torres, Marc De Broe Kidney International

Volume 80, Issue 10, Pages (November 2011)

The hypothesis that abnormal BH4 metabolism impairs kidney function

ANCA comes of age—but with caveats

Stephen G. Rostand, Tilman B. Drüeke Kidney International

Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller

Dana V. Rizk, David G. Warnock Kidney International

The International Pediatric Peritonitis Registry: Starting to walk

Increased fetuin-A levels following treatment with a vitamin D analog

The ins and outs of phosphate homeostasis

In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression B.O. Eriksen, O.C. Ingebretsen Kidney.

Diagram of the mechanisms involved in limiting the ability of the kidney to maintain the levels of 1,25-dihydroxyvitamin D in chronic kidney disease (CKD).

Volume 74, Issue 10, Pages (November 2008)

Marta Christov, Harald Jüppner Kidney International

Ronen Levi, Justin Silver Kidney International

Volume 86, Issue 2, Pages (August 2014)

Presentation transcript:

Use of vitamin D in chronic kidney disease patients Anca Gal-Moscovici, Stuart M. Sprague Kidney International Volume 78, Issue 2, Pages 146-151 (July 2010) DOI: 10.1038/ki.2010.113 Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 1 Progression of changes in calcitriol, parathyroid hormone (PTH), and fibroblast growth factor-23 (FGF-23) with chronic kidney disease (CKD). The early decrease in calcitriol with the increase of FGF-23 before the increase in PTH as CKD develops. Adapted from references 28,33,38, and 39. Kidney International 2010 78, 146-151DOI: (10.1038/ki.2010.113) Copyright © 2010 International Society of Nephrology Terms and Conditions